Gsk PLC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
GSK
Gsk PLCGSK plc, a 10% owner and director, acquired an additional 1.47 million ordinary shares of Wave Life Sciences Ltd. for $19 per share, increasing its total beneficial ownership to over 18.2 million shares.
NYSE
GSK
Gsk PLCGSK plc reports acquiring additional ordinary shares of Wave Life Sciences Ltd., increasing its beneficial ownership.